Provectus Biopharmaceuticals, Inc. Share Price OTC Bulletin Board
Equities
PVCT
US74373P1084
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Sales 2022 | 0.99 82.5 | Sales 2023 | 0.56 46.52 | Capitalization | 40.27M 3.36B |
---|---|---|---|---|---|
Net income 2022 | -3M -250M | Net income 2023 | -3M -250M | EV / Sales 2022 | 4,81,21,944 x |
Net Debt 2022 | 2.16M 180M | Net Debt 2023 | 2.95M 246M | EV / Sales 2023 | 7,75,02,175 x |
P/E ratio 2022 |
-12.8
x | P/E ratio 2023 |
-13
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.58% |
Managers | Title | Age | Since |
---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 71 | 27/18/27 |
Eric A. Wachter
FOU | Founder | 61 | 01/02/01 |
Heather Raines
DFI | Director of Finance/CFO | 58 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric A. Wachter
FOU | Founder | 61 | 01/02/01 |
John W. Lacey
BRD | Director/Board Member | 76 | 27/18/27 |
President | 55 | 03/17/03 |
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- PVCT Stock
- PVCT Stock